Carlton E. Turner

CARLTON E. TURNER is President and Chief Executive Officer of Carrington
Laboratories, Inc., a publicly held biopharmaceutical operating company
listed on NASDAQ that is in the top 50 biotech companies (sales) in the
US. He has over 30 years’ experience as an executive, policy maker,
researcher, scientist, administrator and manager, as well as extensive
experience with national and international law enforcement, intelligence
and development agencies. He has negotiated agreements for the US
government with heads of states and ambassadors throughout the world,
and was a member of the Presidential Mission to the United Nations in
June 1987. Prior to joining Carrington in 1994, he was President and CEO
of Princeton Diagnostic Laboratories of America. Prior to joining PDLA
in 1987, he was an Assistant to President Reagan with cabinet rank
(1981-1987) and was Director of the White House Drug Abuse Policy
Office. The President assigned him the responsibility to rid the
military of drugs. The drug testing was so successful, it is now used
extensively in the private sector. He served on the South Florida Task
Force chaired by Vice President Bush, membership consisting of select
cabinet members. He developed concept papers, coordinated the formation
of and served on the board (with cabinet rank) of the National Narcotic
Border Interdiction System, also chaired by Vice President Bush. During
his stay at the White House, Dr. Turner received Government Executive
magazine’s Manager of the Year Award (1986). Prior to joining the Reagan
Administration, he was Director of the Research Institute of
Pharmaceutical Sciences at the University of Mississippi (1980-1984). As
a director, he was responsible for policies, research programs and
ensuring funding from private sector sources, government sources and the
legislature of Mississippi. As a researcher, Dr. Turner has published
over 125 scientific papers, patents and chapters of books, ranging from
analytical technology of natural products to psychiatry.